Retina 2011™

Program Overview
  Vitreoretinal specialists are faced with varying challenges, including the implementation of new diagnostic and treatment modalities. The goal of this exciting and fast-paced course is to present the most recent advances in the field, while exploring methods of their rational integration into everyday clinical practice.

A renowned faculty has been selected to present this information in both formal lectures and informal discussions. In a relaxed setting, faculty and attendees will discuss specific cases, new therapy and imaging techniques and the latest surgical strategies.		  
     
 

Learn how to apply new diagnostic and treatment
modalities to your practice

  
 
Educational Objectives  
At the conclusion of this activity, attendees should be able to:  
  • Describe the pathogenesis and treatment of dry age-related macular degeneration; provide insights on nutritional therapy, imaging techniques, and new medications.
  • Discuss the use of anti-VEGF agents, as well as optimal dosing strategies,
    for the treatment of choroidal neovascularization in wet age-related macular degeneration.
  • Explain the results of new multicenter trials for the treatment of retinal
    venous occlusion and how to apply the results to patient care.
  • Discuss a review of the latest developments in vitreoretinal surgery technology and how this technology may improve patient outcomes.
  • Identify treatment approaches for retinal inflammatory disorders and posterior uveitis and patients for who these treatments would be beneficial.
  
   
 

Register early and save!

    
 
This continuing medical education activity is jointly sponsored by
Held in conjunction with
  
OCULAR SURGERY NEWS and
Vindico Medical Education
Hawaiian Eye™ 2011
  

 
 

Retina 2011 is supported, in part, by educational grants from Alcon Laboratories, Inc., Allergan and Eyetech, Inc.

ACCREDITATION: This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Ocular Surgery News® and Vindico Medical Education. Vindico Medical Education is accredited by the ACCME to provide continuing medical education for physicians.

CREDIT DESIGNATION: Vindico Medical Education designates this educational activity for a maximum of 25.75 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

FACULTY/PLANNER DISCLOSURE POLICY: In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all planners, teachers, and authors involved in the development of CME content are required to disclose to the accredited provider their relevant financial relationships. Relevant financial relationships will be disclosed to the activity audience.

NOTICE: Faculty, topics, program schedule and credit hours are subject to change. Audiotaping or videotaping is prohibited without written permission from the program director and the Office of Medical Affairs and Compliance.